These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 30029671)

  • 1. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
    Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
    Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.
    Chandler KB; Alamoud KA; Stahl VL; Nguyen BC; Kartha VK; Bais MV; Nomoto K; Owa T; Monti S; Kukuruzinska MA; Costello CE
    Mol Omics; 2020 Jun; 16(3):195-209. PubMed ID: 32203567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.
    Gang EJ; Hsieh YT; Pham J; Zhao Y; Nguyen C; Huantes S; Park E; Naing K; Klemm L; Swaminathan S; Conway EM; Pelus LM; Crispino J; Mullighan CG; McMillan M; Müschen M; Kahn M; Kim YM
    Oncogene; 2014 Apr; 33(17):2169-78. PubMed ID: 23728349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells.
    Kleszcz R; Szymańska A; Krajka-Kuźniak V; Baer-Dubowska W; Paluszczak J
    Cell Oncol (Dordr); 2019 Aug; 42(4):505-520. PubMed ID: 31089983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours.
    Wend P; Fang L; Zhu Q; Schipper JH; Loddenkemper C; Kosel F; Brinkmann V; Eckert K; Hindersin S; Holland JD; Lehr S; Kahn M; Ziebold U; Birchmeier W
    EMBO J; 2013 Jul; 32(14):1977-89. PubMed ID: 23736260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
    Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
    Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.
    Chan KC; Chan LS; Ip JC; Lo C; Yip TT; Ngan RK; Wong RN; Lo KW; Ng WT; Lee AW; Tsao GS; Kahn M; Lung ML; Mak NK
    Sci Rep; 2015 Apr; 5():9979. PubMed ID: 25897700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of β-catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair.
    Moheimani F; Roth HM; Cross J; Reid AT; Shaheen F; Warner SM; Hirota JA; Kicic A; Hallstrand TS; Kahn M; Stick SM; Hansbro PM; Hackett TL; Knight DA
    Int J Biochem Cell Biol; 2015 Nov; 68():59-69. PubMed ID: 26315281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancer.
    Reed ER; Jankowski SA; Spinella AJ; Noonan V; Haddad R; Nomoto K; Matsui J; Bais MV; Varelas X; Kukuruzinska MA; Monti S
    Transl Res; 2023 Oct; 260():46-60. PubMed ID: 37353110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICG-001 suppresses growth of gastric cancer cells and reduces chemoresistance of cancer stem cell-like population.
    Liu Y; Chen H; Zheng P; Zheng Y; Luo Q; Xie G; Ma Y; Shen L
    J Exp Clin Cancer Res; 2017 Sep; 36(1):125. PubMed ID: 28893318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth.
    Arensman MD; Telesca D; Lay AR; Kershaw KM; Wu N; Donahue TR; Dawson DW
    Mol Cancer Ther; 2014 Oct; 13(10):2303-14. PubMed ID: 25082960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Human Airway Epithelial Tissue Stem Cell Differentiation by β-Catenin, P300, and CBP.
    Malleske DT; Hayes D; Lallier SW; Hill CL; Reynolds SD
    Stem Cells; 2018 Dec; 36(12):1905-1916. PubMed ID: 30171668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL
    Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas.
    Li M; Ding X; Zhang Y; Li X; Zhou H; Yang L; Li Y; Yang P; Zhang X; Hu J; Nice E; Wu H; Xu H
    Cell Death Dis; 2020 Aug; 11(8):672. PubMed ID: 32826863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAM83A promotes proliferation and metastasis via Wnt/β-catenin signaling in head neck squamous cell carcinoma.
    Ji H; Song H; Wang Z; Jiao P; Xu J; Li X; Du H; Wu H; Zhong Y
    J Transl Med; 2021 Oct; 19(1):423. PubMed ID: 34641907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
    Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
    J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP).
    Zhou B; Liu Y; Kahn M; Ann DK; Han A; Wang H; Nguyen C; Flodby P; Zhong Q; Krishnaveni MS; Liebler JM; Minoo P; Crandall ED; Borok Z
    J Biol Chem; 2012 Mar; 287(10):7026-38. PubMed ID: 22241478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.